Search

Hg(II) ions in wastewater are highly toxic to the environment and human health, yet many materials to remove the ions exhibit lower adsorption efficiency, and few studies report the reuse of Hg(II)-loaded waste materials. Here, a cheap and efficient adsorbent was prepared for the removal of Hg(II) based on corn bracts (CB) loading copper sulfide (CuS), and the Hg(II)-adsorbed material was reused as a photocatalyst. By changing the adsorption variables such as pH, adsorbent dosage, Hg(II) concentration, contact time and coexisting ions, the optimum adsorption conditions were obtained. The study indicated the adsorption capacity and removal rate of CB/CuS reached 249.58 mg/g and 99.83% at pH 6 with 20 mg CB/CuS, 50 mL Hg(II) concentration (100 mg/L) and 60 min, and coexisting ions did not affect the uptake of Hg(II). The adsorption behavior of CB/CuS toward Hg(II) followed pseudo-second-order and Langmuir models, with the theoretical maximum adsorption capacity of 316.46 mg/g. Finally, we explored an alternative strategy to dispose of spent adsorbents by converting the CB/CuS/HgS into a photocatalyst for the degradation of rhodamine B, with a removal rate of 98%. Overall, this work not only develops a promising material for the treatment of Hg(II)-containing wastewater, but opens up a new approach for the use of the waste adsorbent. HIGHLIGHTS Corn bracts as a carrier of CuS was designed for rapid uptake of Hg(II).; The removal rate of the adsorbent could reach 99.83% in only 60 min.; The theoretical maximum could reach 316.46 mg/g.; Coexisting ions had no significant effect on selective Hg(II) ion removal.; The spent adsorbent was used for photodegradation reaction.;

Multiple osteochondromas (MO) is an inherited skeletal disorder, and the molecular mechanism of MO remains elusive. Exome sequencing has high chromosomal coverage and accuracy, and has recently been successfully used to identify pathogenic gene mutations. In this study, exome sequencing followed by Sanger sequencing validation was first used to screen gene mutations in two representative MO patients from a Chinese family. After filtering the data from the 1000 Genome Project and the dbSNP database (build 132), the detected candidate gene mutations were further validated via Sanger sequencing of four other members of the same MO family and 200 unrelated healthy subjects. Immunohistochemisty and multiple sequence alignment were performed to evaluate the importance of the identified causal mutation. A novel frameshift mutation, c.1457insG at codon 486 of exon 6 of EXT1 gene, was identified, which truncated the glycosyltransferase domain of EXT1 gene. Multiple sequence alignment showed that codon 486 of EXT1 gene was highly conserved across various vertebrates. Immunohistochemisty demonstrated that the chondrocytes with functional EXT1 in MO were less than those in extragenetic solitary chondromas. The novel c.1457insG deleterious mutation of EXT1 gene reported in this study expands the causal mutation spectrum of MO, and may be helpful for prenatal genetic screening and early diagnosis of MO.